ESMO update: upper gastrointestinal cancer

ESMO World Congress on Gastrointestinal Cancer.

This year's annual ESMO World Congress on Gastrointestinal Cancer paid particular attention to the influence of primary tumor sidedness in colorectal cancer as it affects prognosis and treatment outcomes to meet the growing interest in this theory.

ESMO 13th World Congress on Gastrointestinal Cancer

The ESMO World Congress on Gastrointestinal Cancer took place in Barcelona from the 22nd until the 25th of June and hosted just over 3500 participants and faculty members from around the world, representing nearly 100 countries. The meeting mainly covered malignancies affecting the gastrointestinal tract, focusing on personalized therapy and the multidisciplinary approach. In addition, novel mo...

Recent Update of Embolization of Upper Gastrointestinal Tract Bleeding

Nonvariceal upper gastrointestinal (UGI) bleeding is a frequent complication with significant morbidity and mortality. Although endoscopic hemostasis remains the initial treatment modality, severe bleeding despite endoscopic management occurs in 5-10% of patients, necessitating surgery or interventional embolotherapy. Endovascular embolotherapy is now considered the first-line therapy for massi...

Asbestos-Induced Gastrointestinal Cancer: An Update.

Asbestos-related diseases, such as malignancies and asbestosis, remain a significant occupational and public health concern. Asbestos is still widely used in many developing countries despite being a recognized carcinogen that has been banned over 50 countries. The prevalence and mortality from asbestos-related diseases continue to pose challenges worldwide. Many countries are now experiencing ...

Cancer of the upper gastrointestinal tract.